Drug Use Investigation Of Effexor (SECONDARY DATA COLLECTION STUDY; SAFETY AND EFFICACY OF EFFEXOR.UNDER JAPANESE MEDICAL PRACTICE)

• Status: Completed
• Trial end date: 2020-05-11
• Target enrollment: 0
• Participant gender: All

Summary

SECONDARY DATA COLLECTION STUDY; SAFETY AND EFFICACY OF EFFEXOR.UNDER JAPANESE MEDICAL PRACTICE

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer; Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
• Treatments: Venlafaxine Hydrochloride

Criteria

Inclusion Criteria:

• Patients with no experience of using this product who will be administered this product for the first time

Exclusion Criteria:

• Exclusion criteria are not provided in this study